LTZ Therapeutics
Develops immunotherapies to harness myeloid biology for cancer treatment
$38MUndisclosed
Role not disclosedLoading investors…
Activity from announced rounds
Develops immunotherapies to harness myeloid biology for cancer treatment
Develops intelligent platform-driven macrocyclic peptide drug discovery
Pitching GL Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room